Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?
Moderator: Kemi Olugemo, MD, Executive Medical Director, Neurology Clinical Development, Ionis Pharmaceuticals, Inc.
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Speakers:
Kate Burke, MD, Senior Medical Advisor, PatientsLikeMe
Elisabeth Heath, MD, Associate Center Director, Translational Sciences Chair, Genitourinary Oncology Multidisciplinary Team, Karmanos Cancer Institute
Alyshia Merchant, Founder, Making Lupus Look Good
